Kamux Oyj (0RP3)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 1.274 |
|---|---|
| 52-week range | 1.265 – 2.368 |
| Return, 1 month / 3 months | −15.0% / −17.2% |
| Return, 1 year / 3 years | −35.0% / −72.4% |
| Trend | Below its 200-day average |
| RSI (14) | 25 |
| Volatility (1 year) | 29.4% |
| Worst drawdown (1 year) | -45.8% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kamux Oyj is a Finnish retailer of used cars, based in Hämeenlinna. The company runs showroom outlets and an online sales channel, offering pre-owned vehicles to private customers. Alongside the cars themselves, it provides related services such as financing and insurance arrangements for buyers. Its operations span Finland, Sweden and Germany, where it serves retail customers looking for second-hand vehicles through its stores and digital platform.
Kamux Oyj trades under the code 0RP3 on the London Stock Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kamux Oyj (0RP3) trades on the London Stock Exchange in UK. It last closed at EUR 1.274 on 27 October 2026.
Its price-based Market X-Ray is 23 out of 100 (a weak price profile), ranking 3,350 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 35.0% and over the last three months it fell 17.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 14 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -23.8% | ||
| From 52-week high | -45.8% | ||
| Momentum | 16 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.2% | ||
| 6-month return | -23.1% | ||
| 12-month return, skipping the last month | -23.6% | ||
| Stability (higher is calmer) | 44 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.8% | ||
| Liquidity | 11 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.5% |
|---|---|
| 1 month | −15.0% |
| 3 months | −17.2% |
| 6 months | −23.1% |
| 1 year | −35.0% |
| 3 years | −72.4% |
| 5 years | −89.3% |
Signals
| 50-day / 200-day average | 1.480 / 1.672 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.033 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Oct 2025 | EUR 0.0700 |
| 23 Oct 2024 | EUR 0.1000 |
| 19 Apr 2024 | EUR 0.0700 |
| 23 Oct 2023 | EUR 0.1000 |
| 21 Apr 2023 | EUR 0.0500 |
| 20 Oct 2022 | EUR 0.1200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.